首页 › 基金 › WASATCH ADVISORS LP › RGEN
WASATCH ADVISORS LP 对 RGEN 的持仓历史
REPLIGEN CORP · 医疗保健
WASATCH ADVISORS LP 在 Q3 2026 的 13F 申报中披露持有 RGEN(REPLIGEN CORP)907,159 股,市值约 US$174.4M,约占其申报组合的 1.30%,在其申报持仓中市值排名第 18 位。 WASATCH ADVISORS LP 最近 3 个申报季度中有 3 个季度披露了 RGEN 持仓,最早可追溯至 Q1 2026。
最后更新: 2026-10-15 · 来源: SEC EDGAR Form 13F-HR
WASATCH ADVISORS LP 对 RGEN 的持仓演变
WASATCH ADVISORS LP 于 Q1 2026 首次披露 RGEN 持仓:1,243,531 股(约 US$146.5M)。 该持仓在 Q2 2026 达到峰值 1,590,251 股,市值约 US$217.0M。 在 3 次申报中,WASATCH ADVISORS LP 1 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 907,159 股、市值约 US$174.4M,环比减持 -683,092 股。。 持仓曾出现大幅变动:Q2 2026 增持约 28% (随后一个季度股价上涨 41%)、Q3 2026 减持约 43% (随后一个季度股价下跌 7%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2026 | 1.24M | $146.51M | 新进 |
| Q2 2026 | 1.59M | $216.97M | 增持 |
| Q3 2026 | 907.16K | $174.38M | 减持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 RGEN 与 13F 数据
RGEN(REPLIGEN CORP)属于医疗保健行业。我们追踪的基金中还有 32 只申报持有 RGEN,申报仓位最大的包括:UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$380.8M), Maverick 资本 (US$270.8M), MAVERICK CAPITAL LTD (US$270.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 RGEN 的基金
- UNITED CAPITAL FINANCIAL ADVISORS, LLC 2.79M 股 · $380.76M · Q2 2026
- Maverick 资本 1.98M 股 · $270.77M · Q2 2026
- MAVERICK CAPITAL LTD 1.98M 股 · $270.77M · Q2 2026
- CONGRESS ASSET MANAGEMENT CO 1.02M 股 · $196.25M · Q3 2026
- RTW INVESTMENTS, LP 1.24M 股 · $169.27M · Q2 2026
- Conestoga Capital Advisors, LLC 980.98K 股 · $133.85M · Q2 2026
- Stephens Investment Management Group LLC 937.08K 股 · $127.86M · Q2 2026
- FRED ALGER MANAGEMENT, LLC 733.74K 股 · $100.11M · Q2 2026
- DeepCurrents Investment Group LLC 94.44M 股 · $96.80M · Q2 2026
- GENEVA CAPITAL MANAGEMENT LLC 656.09K 股 · $89.52M · Q2 2026
- Aequim Alternative Investments LP 75.00M 股 · $77.09M · Q2 2026
更多关于 WASATCH ADVISORS LP
常见问题
How long has WASATCH ADVISORS LP held RGEN?
WASATCH ADVISORS LP has disclosed RGEN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is WASATCH ADVISORS LP's current position in RGEN?
As of Q3 2026, WASATCH ADVISORS LP holds 907.16K shares of RGEN (REPLIGEN CORP), valued at $174.38M, representing 1.30% of its reported portfolio and ranking #18.
Has WASATCH ADVISORS LP been buying or selling RGEN?
In the latest 13F filing (Q3 2026), WASATCH ADVISORS LP reduced its position in RGEN. The position peaked in Q2 2026 at 1.59M shares.
Which other funds hold RGEN?
Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick 资本, MAVERICK CAPITAL LTD, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.